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Abstract
Background: The use of full-population databases is under-explored to study the use, quality and costs of end-of-life
care. Using the case of Belgium, we explored: (1) which full-population databases provide valid information
about end-of-life care, (2) what procedures are there to use these databases, and (3) what is needed to
integrate separate databases.
Methods: Technical and privacy-related aspects of linking and accessing Belgian administrative databases and
disease registries were assessed in cooperation with the database administrators and privacy commission bodies. For
all relevant databases, we followed procedures in cooperation with database administrators to link the databases and
to access the data.
Results: We identified several databases as fitting for end-of-life care research in Belgium: the InterMutualistic Agency's
national registry of health care claims data, the Belgian Cancer Registry including data on incidence of cancer, and
databases administrated by Statistics Belgium including data from the death certificate database, the socio-economic
survey and fiscal data. To obtain access to the data, approval was required from all database administrators, supervisory
bodies and two separate national privacy bodies. Two Trusted Third Parties linked the databases via a deterministic
matching procedure using multiple encrypted social security numbers.
Conclusion: In this article we describe how various routinely collected population-level databases and disease
registries can be accessed and linked to study patterns in the use, quality and costs of end-of-life care in the
full population and in specific diagnostic groups.
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Background
It has been argued that there is a particular challenge for
end-of-life care research to develop a public health ap-
proach [1] which would include, among other things,
the need for a focus on total populations instead of indi-
viduals at risk or those receiving a certain health care
service. This means that many, often ‘hidden’, publics
also need to be studied [1, 2]. End-of-life care research
indeed often suffers from selection bias, recall bias and
non-response bias [3–5] and difficult-to-reach popula-
tions tend to be under-represented due to ethical and
practical considerations [6].
Administrative data can provide a major opportunity
in this respect. They allow not only the monitoring of
usage, quality and costs of end-of-life care on a popula-
tion level [7], but also identifying populations dying of
or dying with a specific disease such as cancer, chronic
obstructive pulmonary disease (COPD) or Alzheimer’s
disease in order to evaluate patterns of end-of-life care
within and across different trajectories of dying [8].
Many healthcare institutions generate, store and ex-
change large amounts of individual patient data [9]. In-
creasing digitalization in recent years has further
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facilitated and improved this process [10]. Although big
data serve administrative purposes particularly (e.g. billing,
tracking of health care reimbursement) they can provide
useful research material from a public health perspective
[11]. They often have a well-defined population and
include subgroups or difficult-to-reach populations [6].
Because administrative data registrations are usually stan-
dardized and continuously collected they enable trend
analyses and longitudinal studies. Moreover, since the data
have already been collected, they are relatively inexpensive
when compared with original data collections [2, 12]. The
expanding availability and quality of data input make them
increasingly interesting to use in health research. Al-
though full-population databases have been used to study
end-of-life care since the late nineties (e.g. in Australia
[13] and Canada [14]), the use of such data in end-of-life
care research is still under-explored.
End-of-life care researchers may face several chal-
lenges when using administrative data. Administrative
data are, for instance, not specifically designed for re-
search purposes and therefore not directly usable for
the evaluation of quality of care or quality of dying.
They are not structured in readily available variables
for analysis and may often lack the essential disease-
specific or relevant socio-demographic information
needed in end-of-life care research. Additionally, health-
care data, socio-demographic data, socio-economic data
and clinical data gathered on every citizen are stored in
separate databases that are owned and handled by differ-
ent organizations. Also, data security and confidentiality
must be publicly guaranteed when using administrative
databases for healthcare research. The challenge is thus to
collect, link, integrate, store and process them so that they
provide a useful input for end-of-life care research.
Using the case of Belgium, we describe how several
full-population data sources can be accessed, linked,
handled and stored in order to obtain a rich database for
evaluating the use, quality and costs of end-of-life care.
Our research questions are: (1) what data and databases
are available that provide information about end-of-life
care, (2) what are the procedures to obtain/use these
data, (3) what is needed to integrate separate databases,
and (4) what variables are available in these databases to
study use, quality and costs of end-of-life care.
Methods
To address our research aims we systematically collected
the necessary information in four phases:
1. First, we had to identify what databases provide
information on the health care use, quality and costs
near the end of life. We aimed to retrieve healthcare
use data from all decedents for the two years prior
to their death. A group of end-of-life researchers
and health economics experts explored what data
are available on healthcare and medication use that
additionally (1) allow identification of people dying
with or from cancer, Alzheimer’s disease or COPD;
and (2) provide relevant socio-economic and demo-
graphic information that is known from literature to
influence end-of-life care patterns. Health claims
data were used as the starting point as they provide
critical data about patterns in formal care and medi-
cation prescription at the end of life. Other adminis-
trative databases and disease registries were explored
to supplement the health claims database.
2. Once the databases and the data handling
organizations were identified, the associated access
procedures and permissions as well as linking
possibilities were explored.
3. To complete the linking procedure, technical aspects
and privacy protection measures were determined,
explored and followed.
4. Finally, we composed an overview of available
variables through this process. We examined how
they can be used to study use, quality and costs of
end-of-life care.
Results
Identification and selection of databases
A total of seven population-level databases handled by
three different organizations were identified as providing
the necessary information (Table 1).
The Inter Mutualistic Agency (IMA) manages the da-
tabases that included all reimbursement data of health
care consumption from all seven healthcare insurers.
Since health insurance with one of these insurers is le-
gally mandatory in Belgium, reimbursement data of all
legal residents are available in the IMA database. More-
over, thorough quality procedures result in reliable us-
ability of the database for healthcare research. The IMA
manages three databases: (1) a population database con-
taining socio-demographic data of all insured persons;
(2) a health care database containing health care use and
costs data of both ambulatory and hospital care and (3)
a pharmaceutical database containing medication pre-
scription and costs data. The databases thus provide in-
formation on an individual level across the entire
Belgian population. The IMA databases contain no in-
formation regarding medical diagnoses or any disease
specific information.
The Belgian Cancer Registry was identified as a data-
base to identify people who died with cancer. All Belgian
oncological care programmes of hospitals and laborator-
ies for anatomic pathology are legally bound to register
each new cancer diagnosis with the cancer registry. The
latter manages a database with diagnostic information
on all incidences of cancer i.e. date of diagnosis, type of
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cancer and TNM (tumour node metastasis) classification
of malignant tumours [15].
However, the cancer registry data does not make it
possible to distinguish between those who died ‘from’
cancer and those who died ‘with’ cancer. Additionally,
since no similar registries were available to identify those
who died with or from Alzheimer’s disease and COPD
we identified the death certificate data as a necessary
additional database. Death certificate data in Belgium
are collected by three administrations (corresponding to
the three semi-autonomous regions in the country, i.e.
Brussels, Flanders and Wallonia) and are integrated by
Statistics Belgium into one national database for cause
of death statistics. This database provides the causes of
death and associated causes of death (coded in ICD-10
[10th revision of the International Statistical Classifica-
tion of Diseases and Related Health Problems] codes)
for all decedents.
Statistics Belgium also manages the national demo-
graphic database, derived from the population register
[16] and containing for example the household compos-
ition of every citizen and data from the Socio-Economic
Survey 2001 and Census 2011, nationwide full popula-
tion surveys based on the tradition of population count
[17]. The database contains information about the
highest educational level attained, the last held occupa-
tion (as a measure of socio-economic position) and
housing characteristics, which are all socio-economic
factors that have been identified in previous studies as
affecting end-of-life care patterns [18–20]. Finally a data-
base containing fiscal data (i.e. net taxable household in-
come), also managed by Statistics Belgium, was identified
as providing additional socio-economic variables of influ-
ence on end-of-life care patterns.
For more specific clinical data, the Minimal Hospital
dataset, providing clinical information associated with
hospitalizations, was looked at for possible inclusion.
This dataset has high quality data and provides diagnos-
tic information (in ICD-codes), which allows for a more
exact clinical description of the study population. It is
however limited to in-hospital data, limiting the study
population. Additionally, clinical information can be ab-
stracted from health care claims data using specific algo-
rithms. Obtaining cause of death information and using
healthcare claims data makes up for the lack of clinical
data. Therefore inclusion of the Minimal Hospital data-
set was found to be unnecessary.
The combination of identified databases would provide
information on formal health care and medication pre-
scription, causes of death, main diagnosis (through the
Table 1 Overview of population-level databases identified as relevant for end-of-life care research
Database administrators Database name Population Information provided in database
Inter Mutualistic Agency (IMA) Population Database Every Belgian citizen who is a member of
one of the seven (compulsory) Belgian
sickness funds, information in Population
Database is updated twice each year from
2002 onwards
Socio-demographic characteristics
(age, sex, date of death, place of
residence, family composition, use
of supportive measures)
Pharmanet Database Medication supply characteristics
(substance, quantity, prescriber,
expenses, refunds, delivery date)
Medical Claims Database Health and medical care use
characteristics (quantity of use,
reimbursement, supplier, supplier
institution, length of treatment)
Belgian Cancer Registry Cancer registry Every new cancer diagnosis of Belgian
residents, registered by oncological care
programs and laboratories for anatomic
pathology
Diagnostic characteristics (date
of diagnosis, type of cancer, TNM
gradation)
Statistics Belgium Death certificate database Every Belgian decedent with a registered
death certificate
Direct and indirect causes of
death (in ICD-10 codes), socio-
demographics about the deceased,
place of death
Demographic dataset Every Belgian citizen Nationality group, household
composition
Socio-economic survey (SES)
2001 and Census 2011
Every Belgian citizen, information
gathered from multiple external
administrative databases using social
security number (Census 2011)
Highest attained education level,
occupation, housing comfort
IPCAL dataset Every Belgian citizen Net income by category
Identified but not used in our research
Belgian Ministry of Health Minimal Hospital Dataset Every hospital admission in non-
psychiatric general hospitals
Medical, nursery and personnel data
for in-hospital care
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cancer diagnostic information of the cancer registry and
algorithmic estimation methods in the IMA databases),
and various relevant socio-demographic and socio-
economic information.
Access procedures
Two types of approval were needed for every database:
(1) internal approval from database administrator orga-
nizations and (2) approval from the relevant Belgian
Privacy Commission bodies.
(1)To obtain access to the IMA and cancer registry
databases several steps are required. First, a
declaration of interest needs to be set up between
researchers and IMA and cancer registry
programme managers. Research goals, databases,
variables and linking possibilities (see Data linkage
procedure) need to be discussed. After IMA and
cancer registry programme managers agree on
cooperation, the research project (research goals and
requested data) is presented to IMA and cancer
registry directory boards for approval.
To obtain access to the databases administered by
Statistics Belgium, no formal approval of the
directory board is required, since Statistics Belgium
is legally committed to providing data for research.
Based on the requested data, variables and linking
possibilities (see Data linkage procedure) the
statisticians of Statistics Belgium deliver non-binding
advice. Data requests should be filed directly to the
Privacy Committee.
All involved partners then discuss the final selection
of data and variables and initiate preparations for
the linking procedure. The linking of the databases
is a main issue for approval by the involved Privacy
Commission bodies.
(2)We needed the approval of two separate national
sectoral committees for privacy protection for access
to the various databases and the database integrating
all databases: the ‘Sectoral Committee of Social
Security and Health, Section Health’ and the
‘Statistical Supervisory Committee’. Both are
subcommittees of the Belgian Commission for the
Protection of Privacy. The former is responsible for
privacy protection of health care data (IMA and
cancer registry databases), the latter for privacy of
national statistical data (Statistics Belgium
databases). The application to the Sectoral
Committee of Social Security and Health, Section
Health consists of two phases. Phase 1 is the
submission of the application and a first assessment
by the committee in a plenary meeting. The primary
investigator of the study presents the research goals
and data linkage procedure to the committee at this
plenary meeting. In our application special attention
was given to the selection of different variables to
receive data with sufficient detail for analysis, but at
the same time reducing the risk of re-identification
of deceased individuals and their families in order to
preserve privacy. Changes in the linking procedure
and storage on a separate server were requested (see
section on data linkage for more details). Phase 2 is
the formal approval during a second plenary meeting
of the committee, after having received additional
information from the applicant. In our case, the
committee requested an additional risk analysis to
ensure privacy of the included individuals, which
was not requested in the first phase. Formal approval
was granted only after a third plenary meeting. The
full process took six months from application to
formal approval.
The Statistical Supervisory Committee application
procedure consists of one phase in which the
application is assessed and discussed on a plenary
meeting. Formal approval was granted after the
first meeting.
Data linkage procedure
All eligible databases needed to be linked into one inte-
grated database for analysis; a common unique identifier
(i.e. social security number) made deterministic linking
possible. Although the death certificate database does
not contain this unique identifier, Statistics Belgium per-
formed a linkage between the death certificate database
and the national registry database based on date of birth,
sex, and municipality of residence in order to include
this unique identifier as a variable. Unique linkage was
possible for 98.4 % of deaths.1
For privacy reasons, Trusted Third Parties (TTPs)
‘eHealth’ and ‘Crossroads Bank for Social Security (CBSS)’
were responsible for the simple deterministic one-to-one
record linkage of the IMA, cancer registry and Statistics
Belgium databases. The linkage procedure (Fig. 1) con-
sisted of 13 steps of data-coding or decoding and data
transfers needed to ensure that none of the involved par-
ties would have access to both the sensitive data and the
social security numbers or to their own databases
enriched with data from one of the other parties. Only the
researchers have access to the complete linked database
without unique identifiers using a Virtual Private Network
(VPN) connection with secure token.
Linkage of all data for deaths in 2012 (including health
care information about the two years prior to death)
were completed in a first phase of the project. In a sec-
ond phase all data for all deaths 2010-20xx are linked,
where data from subsequent years will be added upon
availability. A major consideration in the decision to
adopt this phased approach is the size of the linked
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Fig. 1 (See legend on next page.)
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database. The linked database (deaths in one year) will
be used for the initial analysis, after which a selection of
variables and/or information can be made. Variables
with too many missing data or variables that are in-
accurate can be dropped. Additionally, the initial analysis
will inform on what health care interventions or medica-
tions are suitable for further analyses. Finally, based on
this first analysis phase, detailed information can be aggre-
gated. The second and third delivery will therefore include
more cases with more condensed information per case.
Since all databases depend on submission by individual
organizations or institutions, a two-year delay is common.
Linkage can only be initiated after all data are complete.
Available information and data handling
Variables selected in this study include data on health care
use, prescribed medication, demographics, socio-economics
and use of special reimbursement rules. A complete list of
variables can be found in Additional file 1: Table S1.
Several steps were necessary to make the data
analysis-ready:
1. In the IMA databases, health care and medication
data are coded as nomenclature and Anatomical
Therapeutic Chemical Classification (ATC) codes. In
order to answer research questions, nomenclature
numbers had to be interpreted and possibly
aggregated by the researchers into meaningful
categories.
2. Due to privacy concerns, no raw dates (e.g. date of
birth, prescription date) were provided by database
administrators. Dates of medication delivery or
health service provision were therefore transformed
into a number of days before death. Combinations
of these recoded dates and nomenclature or ATC
codes are used to determine whether certain
interventions occur within a certain time period
before death.
3. Since no data were provided on diagnosis in the
current set of linked databases (only causes of
death are available), algorithms were used to
abstract diagnostic information from health care
and medication prescription data. Algorithms
were developed to identify people with COPD or
Alzheimer’s disease, based on treatments and
medication received. The algorithms were
developed using existing evidence [21–23] and
were validated by medical experts and medical
data experts from the IMA. They were then applied
by the IMA, prior to the linking procedure, because
data were used that were not available to the
researchers; data provided to the researchers were
limited to two years prior to death, while data used
for identification of patients with Alzheimer’s disease
went back to six years before death. Combinations of
the algorithmic identification of diagnosis and the
causes of death (including the associated causes) can
be used to identify relevant disease groups in the
analyses.
Discussion
Summary of main results
In linking information from seven different datasets
we managed to obtain a database that can provide in-
formation about patterns in the use, quality and costs
of end of life care at the level of the full population and
(See figure on previous page.)
Fig. 1 Step-by-step overview of linkage procedure. IMA DWH: InterMutualistic Agency Data Warehouse; TTP VI CBSS: Trusted Third Party
Crossroads Bank for Social Security; SPOC NIC: Single Point of Contact National InterMutualistic College; BCR: Belgian Cancer Registry; TTP eHealth:
Trusted Third Party eHealth; StatBel BE: Statistics Belgium; SCRA: Small Cells Risk Analysis; SSN: Social Security Number; C1/C2: coding 1/2; Explanatory
note: The linkage procedure consisted of 13 steps (cf. arrows Fig. 1). Step 1: All cases from Belgian decedents since January 1, 2010 are selected in the
IMA databases with their specific identifier coded (C2). These are then decoded (C1) by the TTP VI (CBSS). Step 2: The security officer of the National
InterMutualistic College decodes the identifiers (C1) into actual social security numbers. Step 3.1: The IMA subset of social security numbers is sent by
secure means to the separate TTP eHealth. Step 3.2: TTP eHealth receives the social security numbers from all cases in the Cancer Registry selected for
the study (decedents since January 1, 2010). Step 4.1 and 4.2: To avoid any party from having access to both the sensitive data and the social security
numbers, the established principle of random transport numbers (RN) is used. TTP eHealth assigned these RNs for the selected cases from IMA (4.1)
and BCR (4.2) and provides these RNs to both data agencies in order to transmit the sensitive data safely to the TTP VI (CBSS). Step 4.3: TTP eHealth
recodes the social security numbers into a final code that can be made available to the researchers (Cproject). These are sent, with the RNs as a cross
reference coding, to the TTP VI (CBSS). Step 5: The selected cases and the corresponding requested data from the Cancer Registry are securely
transmitted to the TTP VI (CBSS). Step 6: The selected IMA cases (but not yet the corresponding requested data) are securely transmitted to the TTP VI
(CBSS). Step 7: The selected cases are transferred to the IMA datawarehouse (based on C2) so as to allow the selection of all data corresponding to
these cases. Step 8: The selected cases and the corresponding requested data from IMA are securely transmitted to the TTP VI (CBSS). Step 9: The
social security numbers and corresponding RNs are transferred safely to Statistics Belgium in order to allow selection of the correct cases. A social
security number has already been attributed by Statistics Belgium to every case in the death certificate data (which do not contain the social security
numbers) based on a deterministic linkage between the death certificate database and the national registry database based on date of birth, sex, and
municipality of residence. Step 10: Statistics Belgium sends the requested data from the selected cases to TTP VI (CBSS) who links these with the data
from IMA and Cancer Registry using the RNs. Step 11: The TTP VI (CBSS) recodes all data one final time based on the Cproject coding. Step 12: A small
cells risk analysis is performed to minimize the risk of re-identification based on a combination of variables. Step 13: The complete linked database is
stored on a separate IMA data server, which is only accessible to the researchers through a Virtual Private Network (VPN) connection with secure token
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their associations with various clinical, socio-
demographic, socio-economic and environmental factors.
The process of obtaining this involved detailed identifica-
tion of databases fitting the study aims, negotiation with
and formal approval of three database administrators,
three supervisory bodies and two national privacy com-
missions and eventual linking of all databases through two
Trusted Third Parties (TTPs) using multiple encrypted so-
cial security numbers.
We believe that the described process can be particu-
larly helpful to researchers in other countries in compil-
ing similar population-level databases on end-of-life
care. A number of considerations (limitations, strengths
and opportunities) and recommendations can be made
based on our experience.
Limitations of our study
Our study involved a systematic and thorough explor-
ation of how several databases providing information on
end-of-life care can be accessed, handled and linked into
an integrated and enriched database. However, an im-
portant limitation is that linkage with information on
patient-related outcomes of healthcare services, such as
specific Patient Reported Outcome Measures (PROMs)
was not explored in our study. Even though PROMs are
important indicators to evaluate whether increased
healthcare expenditure results in better health outcomes,
their inclusion in a population-level database is only
meaningful if there is sufficient standardization in the
measurement methodology. In Belgium, a common cod-
ing system for PROMs is lacking and would be time-
consuming to perform. [24] Future efforts could be
made to include PROMs at a population level.
Opportunities of the collected database
Our efforts resulted in a population-level database with
detailed information about formal end-of-life care, the
costs of care and demographic, socio-economic and
diagnostic information on decedents. The opportunities
provided by such a database to study use, quality and
costs of end-of-life care are considerable. The main
overall advantage is that data are population-level and
therefore not subject to sample bias such as in surveys
or medical records studies of selected groups of patients.
Compared to primary data collection, using linked rou-
tinely collected databases as in our case is less expensive
and less time-consuming. In the end-of-life care context
specifically, primary data collection can be burdensome
for patients and caregivers. Furthermore, in routinely
collected databases, high-quality data are available on
the spot, although they are not deliberately collected for
research aims.
Although the linked database does not include certain
types of information that are important in evaluating
quality of care, such as patient-specific preferences of
care, psycho-social information, patient or family re-
ported outcomes and experiences or information about
pain and symptom management or communication as-
pects [25], the full-population data have the potential to
provide robust and population-level measures of the
quality of end-of-life care using specific claims-based
quality indicators. These quality indicators, e.g. mapping
inappropriate end-of-life care, have been used in various
studies as measures for the quality of end-of-life care
[26]. If preceded by an adequate validation process, they
can provide a detailed image of the quality of end-of-life
care by regions or health care providers [26]. The linked
database also contains data on all direct medical costs
and reimbursed service and medication use, which offers
opportunities to study direct medical costs and patterns
in the use of specific end-of-life care for full populations.
Policy measures that support palliative care include fi-
nancial compensation directed towards the patient (e.g.
monthly lump sum to cover additional costs for pallia-
tive home patients). Using this database, patterns in the
uptake of these measures can be mapped and compared
between population or pathology groups. As the linked
database contains individual data, these data can be ag-
gregated on multiple levels, which makes longitudinal,
disease-, treatment- or provider-specific analyses pos-
sible. As a result, it is also possible to evaluate the influ-
ence of certain policy measures and governmental
support programmes. Without the rich population-level
data we collected it would be impossible to answer these
example research questions without facing major issues
of reliability, generalizability, feasibility and costs.
Data allow us to follow back the treatment history
and costs of those treatments up to two years before
death. Although a shorter period before death may be
sufficient to study several aspects of end-of-life care
in specific disease groups, for other (particularly non-
cancer) longer time periods are warranted. The deci-
sion to request all health care and medication data
up to two years before death (irrespective of when
the diagnosis was made) was also made for practical
reasons as going further back would substantially in-
crease storage and analysis requirements.
Limitations of the collected database
A limitation of these types of routinely collected
population-level data is that services not covered by in-
surers are not included. Researchers from other coun-
tries that wish to compile a similar database need to
remember that what is not covered by insurance (and
hence not found in the data) may be country- or even
region-specific. In Belgium, data are relatively complete,
for health care services in the hospital, nursing homes and
at home. Nevertheless use of certain services cannot be
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identified because there is no individual reimbursement
(e.g. mobile hospital palliative care teams) or such reim-
bursement is not regulated or generalized (e.g. consulta-
tions of a psychologist). Secondly, total out-of-pocket
spending is not available in the integrated database. This
results in an overall underestimation of the total cost of
end-of-life care. Nevertheless, administrative data are an
essential source of information for studies on the financial
burden of end-of-life care for the health care budget and
are valuable for policymakers in informing their decisions
on health care policy [8].
Considerations and actions for researchers considering
similar database constructions (Table 2)
The linkage process is crucial in obtaining a useful
population-level database. It enables the enriching of the
population-level data on formal end-of-life care and the
costs of that care with putative demographic, socio-
economic and diagnostic information for the study of
end-of-life care patterns. This allows the development of
explanatory models and the provision of public health in-
formation to policy makers, for example on social differ-
ences and differences between pathology groups. It can
support discussions on the organization of the health care
system, based for instance on possible existing inequities.
The flip side is that the linking can create additional
difficulties in the process of obtaining the data. While
deterministic linking is relatively easy to complete on a
technical level (even without identical unique identifiers
a deterministic linking is possible based on a combin-
ation of variables), the main challenges for researchers
lie in the fact that 1) several separate organizations have
to be convinced to cooperate and 2) special attention
needs to be given to privacy-related issues.
Databases across health and social care may not always
contain a unique identifier variable, or not always con-
tain accurate and fully available information that allows
identifying unique persons. In such cases where the pos-
sibility to perform deterministic linkage is limited the
method of probabilistic linking can present a solution.
In this approach the likelihood of a correct linking is cal-
culated and a linking is done when the likelihood is suf-
ficiently large [27]. Several tools have been developed to
perform this probabilistic linking [28]. Nevertheless, a
lack of accurate and fully available personal identifiable
information constrains a probabilistic linking method.
A final consideration for researchers who wish to have
access to similar data in their country is that establishing
and maintaining good relationships with database ad-
ministrators is crucial. Gaining access to administrative
data is an iterative process that requires a lot of prepara-
tory work. Database administrators are the researchers’
access points to the data and have all the information
about internal procedures. Strict procedures need to be
Table 2 Considerations for researchers planning to link databases
Topics Considerations
Exploring relevant databases Are my research questions clear and well-defined? What data are needed to answer them?
What is/are my study population(s)? What data are needed to identify it?
What database(s) contains the core data and could thus be selected as a starting point?
When a starting database is chosen, what data are lacking to fully address the research questions?
Where can we find them?
How can we establish contact with the database administrators of the databases? Obtain principal
approval from all administrators (e.g. by presenting the study to the board of directors)
What is the cost associated with each database?
Variable selection What specific variables do we need from the selected databases to answer our research questions?
Are the variables we want available and linkable between the different databases?
Does the preferred selection of variables complicate the linking procedure considerably? Balance the
gain in information with the increase in complexity and time.
What is the required level of detail for each variable? Balance the preferred level with what is allowed in
terms of data protection (e.g. through small cells risk analysis to determine risk of re-identification based
on a combination of variables)
Do we have sufficient storage capacity and analysis hardware to store and analyze all the data we want?
Access procedures What ethical and privacy procedures need to be followed to link and access the selected database?
What technical procedures need to be followed to link and access the selected databases?
Infrastructure How will data be stored safely? Is infrastructure provided by researchers or by database administrators?
What is the cost for this infrastructure?
How will data be protected? Physical and digital protection need to be guaranteed.
How can data be accessed in a safe and easy way? What hardware and software do we need to access
and analyze the requested data?
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followed, in close cooperation with database administra-
tors. We were able to arrange an updated dataset where
data from subsequent years will be added upon availabil-
ity in the same approval and agreement, which limits the
time of going through all necessary permissions each
time an updated dataset is needed. Since administrative
data are often not gathered with the intention of re-
search, or only for internal use, the process of making
the data analysis-ready can take time. Researchers must
adapt to how data are registered and stored, before they
can effectively use them for research.
Conclusion
Linking and accessing various routinely collected
population-level databases involves challenges but offers
substantial opportunities to study patterns in the use,
quality and costs of end-of-life care both in the full
population and for specific diagnostic groups. This study
has identified that it is possible to combine data from
different databases in order to obtain a rich database for
such analysis, including information about all reim-
bursed care and medication as well as disease, demo-
graphic, socio-economic and environmental information.
While some aspects may be specific to the Belgian con-
text, our study has a much broader application as most
developed countries collect similar population-level da-
tabases. The process described in our study can be a
helpful aid for researchers in these countries to compile
similar data and eventually develop an international
comparative end-of-life care research agenda using ad-
ministrative health care data.
Endnote
1Between 1998 and 2013, 1,662,550 of 1,689,740
deaths were matched (98.39 %).
Additional file
Additional file 1: Table S1. Complete list of variables in the linked
dataset (IMA – Statistics Belgium – BCR). (DOCX 22 kb)
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